PHYTOCANNABINOIDS FOR USE IN THE TREATMENT OF CANCER
    3.
    发明申请
    PHYTOCANNABINOIDS FOR USE IN THE TREATMENT OF CANCER 审中-公开
    用于治疗癌症的PHYTOCANNABINOIDS

    公开(公告)号:US20140221469A1

    公开(公告)日:2014-08-07

    申请号:US14343877

    申请日:2012-09-10

    摘要: The present invention relates to the use of phytocannabinoids in the treatment of cancer. More particularly it relates to the use of phytocannabinoids in the treatment of tumour cell invasion and cell migration or metastases. Cancers, where invasion and cell migration plays a key role in prognosis include brain tumours, more particularly gliomas, and most particularly Glioblastoma multiforme (GBM) and breast cancers. The phytocannabinoids tetrahydrocannabivarin (THCV) and cannabidivarin (CBDV) alone or in combination with each other and/or other phytocannabinoids, particularly cannabidiol (CBD), tetrahydrocannabinol (THC) and cannabigerol (CBG) or their respective acids are of particular use.

    摘要翻译: 本发明涉及植物大麻素在癌症治疗中的应用。 更具体地说,它涉及植物大麻素在治疗肿瘤细胞侵袭和细胞迁移或转移中的应用。 侵袭和细胞迁移在预后中起关键作用的癌症包括脑肿瘤,尤其是神经胶质瘤,特别是多形性成胶质细胞瘤(GBM)和乳腺癌。 单独使用或与其他植物大变性动物,特别是大麻二酚(CBD),四氢大麻酚(THC)和大麻酚(CBG)或其各自的酸组合的植物大丁素四氢大戟素(THCV)和大麻素(CBDV))是特别有用的。